NCT00569998 - Comparison of Two Pen Systems in Patients With Diabetes Treated With Insulin | Biotech Hunter

Enrollment

208

Participants

Timeline

Start Date

August 31, 2003

Primary Completion Date

February 29, 2004

Study Completion Date

February 29, 2004

Conditions

DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2Delivery Systems

Interventions

DEVICE

NovoPen™ 4

DEVICE

NovoPen® 3

Trial Locations (23)

1090

Novo Nordisk Investigational Site, Vienna

10144

Novo Nordisk Investigational Site, Torino

43100

Novo Nordisk Investigational Site, Parma

50858

Novo Nordisk Investigational Site, Cologne

51373

Novo Nordisk Investigational Site, Leverkusen

66333

Novo Nordisk Investigational Site, Völklingen

66386

Novo Nordisk Investigational Site, Saint Ingbert

67346

Novo Nordisk Investigational Site, Speyer

81377

Novo Nordisk Investigational Site, München

90127

Novo Nordisk Investigational Site, Palermo

95122

Novo Nordisk Investigational Site, Catania

A 1090

Novo Nordisk Investigational Site, Vienna

00165

Novo Nordisk Investigational Site, Roma

1315 RA

Novo Nordisk Investigational Site, Almere Stad

1081 HV

Novo Nordisk Investigational Site, Amsterdam

6419 PC

Novo Nordisk Investigational Site, Heerlen

3015 GD

Novo Nordisk Investigational Site, Rotterdam

2512 VA

Novo Nordisk Investigational Site, The Hague

5504 DB

Novo Nordisk Investigational Site, Veldhoven

BT12 6BE

Novo Nordisk Investigational Site, Belfast

BT37 9RH

Novo Nordisk Investigational Site, Belfast

LS9 7TF

Novo Nordisk Investigational Site, Leeds

DA14 6LT

Novo Nordisk Investigational Site, Sidcup